Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
This study is ongoing, but not recruiting participants.
Study NCT00062231 Information provided by National Cancer Institute (NCI)
First Received: June 5, 2003 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fever, Sweats, and Hot Flashes
Infection
Leukemia
Lymphoma
Myelodysplastic Syndromes
Neutropenia
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Communicable Diseases
Fever
Hot Flashes
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Multiple Myeloma
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms, Plasma Cell
Precancerous Conditions
Preleukemia
Syndrome
More general conditions related to this trial
Agranulocytosis
Blood Protein Disorders
Body Temperature Changes
Bone Marrow Diseases
Cardiovascular Diseases
Disease
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Leukocyte Disorders
Leukopenia
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Paraproteinemias
Pathologic Processes
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
amoxicillin-clavulanate potassium
ciprofloxacin
moxifloxacin hydrochloride
management of therapy complications
Additional drug interventions recognized in this trial
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Clavulanic Acid
Moxifloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
European Organization for Research and Treatment of Cancer
Back to top of Main Content